Drug
Foralumab
Foralumab is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_2
3
75%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 3 finished
Non-Completion Rate
100.0%
3 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Terminated(3)
Detailed Status
Withdrawn3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
withdrawn375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
NCT06292923
withdrawnphase_1
A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease
NCT05028946
withdrawnphase_2
In-patient COVID-19 Study of Intranasal Foralumab
NCT04983446
withdrawnphase_2
Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM
NCT03291249
Clinical Trials (4)
Showing 4 of 4 trials
NCT06292923Phase 2
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
NCT05028946Phase 1
A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease
NCT04983446Phase 2
In-patient COVID-19 Study of Intranasal Foralumab
NCT03291249Phase 2
Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4